Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Jul05310473John Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1554147770352762887.png) @Jul05310473John Biotechdruganalyst

Biotechdruganalyst posts on X about $crbp, $mrus, $8bn, market cap the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1554147770352762887/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1554147770352762887/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXX +488%
- X Months XXXXXX +223%
- X Year XXXXXX -XXXX%

### Mentions: X [#](/creator/twitter::1554147770352762887/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1554147770352762887/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX +213%
- X Months XXX +158%
- X Year XXX -XX%

### Followers: XXX [#](/creator/twitter::1554147770352762887/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1554147770352762887/c:line/m:followers.svg)

- X Week XXX +1.70%
- X Month XXX +11%
- X Months XXX +31%
- X Year XXX +50%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1554147770352762887/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1554147770352762887/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1554147770352762887/influence)
---

**Social category influence**
[finance](/list/finance)  XXXXX% [stocks](/list/stocks)  XXXX%

**Social topic influence**
[$crbp](/topic/$crbp) #3, [$mrus](/topic/$mrus) #12, [$8bn](/topic/$8bn) 11.11%, [market cap](/topic/market-cap) 11.11%, [$skye](/topic/$skye) 5.56%, [$nvo](/topic/$nvo) 5.56%, [weight loss](/topic/weight-loss) 5.56%, [nvo](/topic/nvo) 5.56%, [$200mm](/topic/$200mm) 5.56%, [$cadl](/topic/$cadl) XXXX%

**Top accounts mentioned or mentioned by**
[@hannibalspeaks](/creator/undefined) [@biotenic](/creator/undefined) [@pedro3236143411](/creator/undefined) [@aaronrosenblum5](/creator/undefined) [@paulpetertak](/creator/undefined) [@candeltx](/creator/undefined) [@bwalkerttaggg](/creator/undefined) [@jessebrodkin](/creator/undefined) [@biovalues](/creator/undefined) [@persimmonti](/creator/undefined) [@andreagtc](/creator/undefined) [@kingachillese](/creator/undefined) [@investseekers](/creator/undefined) [@rnaianalyst](/creator/undefined) [@bigpharmaguy](/creator/undefined)

**Top assets mentioned**
[Merus N.V. Common Shares (MRUS)](/topic/$mrus) [Novo-Nordisk (NVO)](/topic/$nvo) [Bitcoin Incognito (XBI)](/topic/$xbi)
### Top Social Posts [#](/creator/twitter::1554147770352762887/posts)
---
Top posts by engagements in the last XX hours

"@KingachillesE If $crbp nectin-4 ADC at ESMO25 is equal or better than $mrus peto data the stock could trade up to as high as XX% of $mrus $8bn valuation=$ XXX mm market cap=$65 per share . Definitely at least 2-3 bagger if data good"  
[X Link](https://x.com/Jul05310473John/status/1973425733252030593) [@Jul05310473John](/creator/x/Jul05310473John) 2025-10-01T16:32Z XXX followers, XXX engagements


"@hannibalspeaks @Biotenic $crbp competitor $skye failed. $nvo Monlunabant induced potent weight loss but still plagued by neuropsych and surprisingly high rate of GI toxicity. $crbp is last man standing in CB1. We know CRB-913 will induce W/L and if safety profile is clean drug will be blockbuster"  
[X Link](https://x.com/Jul05310473John/status/1976981908467921127) [@Jul05310473John](/creator/x/Jul05310473John) 2025-10-11T12:03Z XXX followers, XXX engagements


"@BioValues Not $crbp Nectin X ADC data at #ESMO25. If HNSCC data is equal or better than $mrus stock is going way higher a double or triple. Stock still way cheap at $200mm market cap"  
[X Link](https://x.com/Jul05310473John/status/1979131280961786069) [@Jul05310473John](/creator/x/Jul05310473John) 2025-10-17T10:24Z XXX followers, XXX engagements


"@BWalkerTTAGGG @paulpetertak @CandelTx Bull crap on Trinity . Real truth is $CADL cant raise sufficient equity capital . In a binary debt is great if you win but there is a much higher probability of losing"  
[X Link](https://x.com/Jul05310473John/status/1978858831917490447) [@Jul05310473John](/creator/x/Jul05310473John) 2025-10-16T16:21Z XXX followers, XXX engagements


"@RNAiAnalyst $xbi going much higher . Biotech bull market just getting started . Big pharma has huge LOE cliff . Many more M&As to come"  
[X Link](https://x.com/Jul05310473John/status/1979134255608336535) [@Jul05310473John](/creator/x/Jul05310473John) 2025-10-17T10:35Z XXX followers, XXX engagements


"@bigpharmaguy @AaronRosenblum5 @BioValues I dont think so because the big prize and the reason $gmab paid $8bn is 1L. obviously much bigger TAM for 1L . Once Pete 1L is approved it wont be used in 2L. 2L is wide open for $crbp. Response rates in 2L for chemo pembro and centuximab only 10-20%. 2L TAM is $1.5bn+"  
[X Link](https://x.com/Jul05310473John/status/1979139193625362579) [@Jul05310473John](/creator/x/Jul05310473John) 2025-10-17T10:55Z XXX followers, XXX engagements


"$crbp Nectin X ADC data at #ESMO25 -rapid enrollment for PH1 study-167 patients enrolled & XXX evaluable including XX HNSC pts. If HNSCC data is equal or better than $mrus stock will rock- XX% of MRUS 7bn t/o=$800mm=$65 stock price"  
[X Link](https://x.com/Jul05310473John/status/1978074353825718583) [@Jul05310473John](/creator/x/Jul05310473John) 2025-10-14T12:24Z XXX followers, XXX engagements


"@AaronRosenblum5 @PersimmonTI Dude youre so biased they just started combo data and it makes sense to start in 2L to see what shakes our in 1L"  
[X Link](https://x.com/Jul05310473John/status/1980762075874971954) [@Jul05310473John](/creator/x/Jul05310473John) 2025-10-21T22:24Z XXX followers, XX engagements


"@AaronRosenblum5 @PersimmonTI Maybe but maybe not they have money in the bank and much stronger institutional ownership and support than pyxs. Btw if PYXS succeeds it will be a real sleeper. I dont hear a buzz at all from the street or clinicians"  
[X Link](https://x.com/Jul05310473John/status/1980767149431091633) [@Jul05310473John](/creator/x/Jul05310473John) 2025-10-21T22:44Z XXX followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Jul05310473John Avatar @Jul05310473John Biotechdruganalyst

Biotechdruganalyst posts on X about $crbp, $mrus, $8bn, market cap the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXXXX -XX%
  • X Month XXXXXX +488%
  • X Months XXXXXX +223%
  • X Year XXXXXX -XXXX%

Mentions: X #

Mentions Line Chart

  • X Week XX -XX%
  • X Month XX +213%
  • X Months XXX +158%
  • X Year XXX -XX%

Followers: XXX #

Followers Line Chart

  • X Week XXX +1.70%
  • X Month XXX +11%
  • X Months XXX +31%
  • X Year XXX +50%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence finance XXXXX% stocks XXXX%

Social topic influence $crbp #3, $mrus #12, $8bn 11.11%, market cap 11.11%, $skye 5.56%, $nvo 5.56%, weight loss 5.56%, nvo 5.56%, $200mm 5.56%, $cadl XXXX%

Top accounts mentioned or mentioned by @hannibalspeaks @biotenic @pedro3236143411 @aaronrosenblum5 @paulpetertak @candeltx @bwalkerttaggg @jessebrodkin @biovalues @persimmonti @andreagtc @kingachillese @investseekers @rnaianalyst @bigpharmaguy

Top assets mentioned Merus N.V. Common Shares (MRUS) Novo-Nordisk (NVO) Bitcoin Incognito (XBI)

Top Social Posts #


Top posts by engagements in the last XX hours

"@KingachillesE If $crbp nectin-4 ADC at ESMO25 is equal or better than $mrus peto data the stock could trade up to as high as XX% of $mrus $8bn valuation=$ XXX mm market cap=$65 per share . Definitely at least 2-3 bagger if data good"
X Link @Jul05310473John 2025-10-01T16:32Z XXX followers, XXX engagements

"@hannibalspeaks @Biotenic $crbp competitor $skye failed. $nvo Monlunabant induced potent weight loss but still plagued by neuropsych and surprisingly high rate of GI toxicity. $crbp is last man standing in CB1. We know CRB-913 will induce W/L and if safety profile is clean drug will be blockbuster"
X Link @Jul05310473John 2025-10-11T12:03Z XXX followers, XXX engagements

"@BioValues Not $crbp Nectin X ADC data at #ESMO25. If HNSCC data is equal or better than $mrus stock is going way higher a double or triple. Stock still way cheap at $200mm market cap"
X Link @Jul05310473John 2025-10-17T10:24Z XXX followers, XXX engagements

"@BWalkerTTAGGG @paulpetertak @CandelTx Bull crap on Trinity . Real truth is $CADL cant raise sufficient equity capital . In a binary debt is great if you win but there is a much higher probability of losing"
X Link @Jul05310473John 2025-10-16T16:21Z XXX followers, XXX engagements

"@RNAiAnalyst $xbi going much higher . Biotech bull market just getting started . Big pharma has huge LOE cliff . Many more M&As to come"
X Link @Jul05310473John 2025-10-17T10:35Z XXX followers, XXX engagements

"@bigpharmaguy @AaronRosenblum5 @BioValues I dont think so because the big prize and the reason $gmab paid $8bn is 1L. obviously much bigger TAM for 1L . Once Pete 1L is approved it wont be used in 2L. 2L is wide open for $crbp. Response rates in 2L for chemo pembro and centuximab only 10-20%. 2L TAM is $1.5bn+"
X Link @Jul05310473John 2025-10-17T10:55Z XXX followers, XXX engagements

"$crbp Nectin X ADC data at #ESMO25 -rapid enrollment for PH1 study-167 patients enrolled & XXX evaluable including XX HNSC pts. If HNSCC data is equal or better than $mrus stock will rock- XX% of MRUS 7bn t/o=$800mm=$65 stock price"
X Link @Jul05310473John 2025-10-14T12:24Z XXX followers, XXX engagements

"@AaronRosenblum5 @PersimmonTI Dude youre so biased they just started combo data and it makes sense to start in 2L to see what shakes our in 1L"
X Link @Jul05310473John 2025-10-21T22:24Z XXX followers, XX engagements

"@AaronRosenblum5 @PersimmonTI Maybe but maybe not they have money in the bank and much stronger institutional ownership and support than pyxs. Btw if PYXS succeeds it will be a real sleeper. I dont hear a buzz at all from the street or clinicians"
X Link @Jul05310473John 2025-10-21T22:44Z XXX followers, XX engagements

@Jul05310473John
/creator/twitter::Jul05310473John